Announcing the Launch of Cancer Immunology Connect
Published at 15 August 2024
Scifiniti is pleased to announce the launch of our latest journal, Cancer Immunology Connect, under the esteemed leadership of Dr. Eyad Elkord from Xi’an Jiaotong-Liverpool University, China. This peer-reviewed, open-access journal is dedicated to advancing the understanding of the complex interactions between cancer cells and the immune system.
We invite you to explore our journal and consider submitting your research. For more information, please visit https://scifiniti.com/